AIM movers: Conroy Gold intersections and Petro Matad slumps on fundraising

1

Conroy Gold and Natural Resources (LON: CGNR) is rising on the back of Thursday’s news of gold lodes intersected between the Clontibret gold deposit and Corcaskea gold target. There are three gold lode zones with grades of up to 8.3g/t gold over 0.5 of a metre. This increases the potential for the 65km gold trend in Ireland. The share price increased by 15.7% to 14.75p.

88 Energy (LON: 88E) has recovered following yesterday’s fall when it announced it was raising up to £8.1m (A$15.1m) at 0.55p a share, which was a one-fifth discount to the previous closing price. The share price has recovered 12.5% to 0.675p. The cash will fund the Hickory-1 well at project Phoenix (formerly Icewine East) in Alaska, pay for new project Leonis acreage and provide working capital. There should be enough cash for at least 12 months.

Harvest Minerals (LON: HMI) share are moving upwards following an investor presentation earlier in the week. The share price has risen 7.58% to 8.875p.

Fintech Tintra (LON: TNT) has appointed Constantine Chikosi as director for strategic initiatives for Africa. The share price has been falling this week and it perked up 6.67% to 160p.

Immotion (LON: IMMO) continues to rise on the back of the disposal of the location-based entertainment business for $25.1m and a promised 3p a share dividend. There will be £6.5m of the proceeds left to invest in the remaining business. The share price improved a further 6.25% to 3.4p.

Late on Thursday, Mongolia-focused oil and gas producer Petro Matad (LON: MATD) launched a fundraising and that raised £4.9m at 2.5p a share. That is 50% more than the minimum that was sought. A retail offer could raise up to £500,000 more. The share price slumped 34.2% to 2.7p. The cash will fund the testing of the low-cost, high impact Velociraptor prospect, as well as evaluating other oil licence areas and renewable energy projects.

Morses Club (LON: MCL) gained 75.17% backing to approve the cancellation of the quotation on AIM. This resolution required 75% of the vote so it only just succeeded. Shareholders owning 61.7% of the share capital voted. The last day of dealings will be 10 February. After that, there will be a matched bargain facility on Asset Match.  The share price dived by one-third to 0.4995p.

Sustainable polymers developer Itaconix (LON: ITX) has raised £10.3m at 5.1p a share, while an open offer could raise up to £400,000. The share price slipped by 3.74% to 5.15p. The cash will fund product development, capital investment and working capital. The 2022 revenues more than doubled to $5.6m, which is better than expected. Tertiary Minerals (LON: TYM) is raising £300,000 at 0.12p a share, while the share price fell 3.57% to 0.135p. The cash will be spent on copper projects in Zambia and Nevada. Drilling is expected in Zambia later this year.

Shell, Amazon, and Avacta with Alan Green

Alan Green joins the Podcast as we delve into global equities and the key themes driving markets this week.

We discuss:

  • Shell (LON:SHEL)
  • Amazon (NASDAQ:AMZN)
  • Avacta (LON:AVCT)
  • AQUIS (LON:AQX)

We look at Shell’s record profits and what the company needs to do in future to support the share price. The company says it will invest their bumper profits in renewables, we question how realistic these claims are.

Amazon is feeling the pressure of a slowing global economy reflected in stuttering growth in their international sales. We look at whether Amazon will be seen as a momentum stock or value stock going forward.

Alan finishes by running through the latest news from Avacta and AQUIS.

Tekcapital shares jump after Innovative Eyewear surges on the NASDAQ

Tekcapital shares jumped 22% to the highest level since September last year after shares in their portfolio company Innovative Eyewear surged in the US.

NASDAQ-listed Innovative Eyewear was over 200% higher at the time of writing on Thursday.

Tekcapital hold a 70% stake in Innovative Eyewear and today’s rise represents a gain in the value of TEK’s holding in the region of $14m.

Innovative Eyewear have developed a range of smart eyewear and partnered with major brands including Nautica, and more recently, Eddie Bauer.

“Few names are as renowned as Eddie Bauer in outdoor recreation,” said Harrison Gross, CEO of Innovative Eyewear, at the time the Eddie Bauer partnership was announced in December.

“Our Eddie Bauer smart eyewear collection, powered by Lucyd, will continue Eddie Bauer’s legacy of bold and beautiful craftsmanship, coupled with innovation, and will align perfectly with today’s adventurous lifestyles. We believe outdoor enthusiasts are looking for designer eyewear that both protects their vision and allows them to remain connected to their digital lives in an open-ear, handsfree format.”

Innovative Eyewear technology has the potential to save a great number of lives by reducing the distractions associated with handheld devices.

FTSE 100 gains after Bank of England hikes rates, US Stocks surge

The FTSE 100 finished Thursday higher after the Bank of England raised rates by 50bps to 4% and signalled a milder UK recession than first thought.

The Bank of England also amended their inflation forecast to just 4% by the end of the year.

“The Bank is now projecting that inflation will fall to 4% by the end of the year, which will be music to the ears of the PM, who has promised a halving in the inflation rate – though the Bank might legitimately be a little peeved the government is trying to claim credit for their efforts,” said Laith Khalaf, head of investment analysis at AJ Bell.

“Inflation is now forecast to fall to 0.4% in 2026, which begs the question why the Bank is continuing to raise interest rates.”

The Bank of England was joined by the ECB in hiking 50bps on Thursday. However, the biggest story in town was the US Federal Reserve’s more conservative 25bps rate hike last night.

The slowing pace of US rate hikes and generally dovish comments from the Federal Reserve Chair proved ample to support global risk assets and the Bank of England’s instalment helped boost momentum in equity markets.

The Federal Reserve said that although rates would continue to rise in 2023, it would be at a slower pace than 2022. Bond yields fell across major economies as a result – this is welcome news for equity investors.

The Fed Chair really fired up equity bulls when as he said the “disinflationary process has started”, opening the doors for easier monetary policy in the future.

The FTSE 100 touched 7,840 in mid afternoon trade before falling back to 7,820 at the close. US stocks stormed ahead with the S&P 500 jumping 1.5% and the NASDAQ surging 3%.

Shell record profits

Shell provided substantial support for the index on Thursday following the confirmation of record profits in 2022 due to higher energy prices. Shell earnings hit $40bn in 2022, although some areas of the business started to slow down in the 4th quarter.

Following a sharp rally in Facebook-owner Meta last night and the NASDAQ today, Ocado once more demonstrated its tech stock attributes as it jumped 11% in a broad global tech rally.

The tech-heavy Scottish Mortgage Trust was also among the top risers, gaining 6%. The trust’s largest holdings include Tesla, Tencent, and Amazon. Moderna is the trust’s top holding, accounting for 10% of the portfolio.

JD Sports also gained 11% meaning the retailer has nearly doubled from lows at the end of 2022. The prospect of lower inflation could mean increased discretionary spending on JD’s £160 trainers.

AIM movers: Immotion cash return and ex-dividends

2

Immotion (LON: IMMO) is selling its location-based entertainment business for $25.1m, having raised £100,000 from disposing of Uvisan. Shareholders are likely to receive 3p a share out of the sale proceeds with £6.5m retained for the remaining business after buying back shares from management leaving with the location-based entertainment business. Immotion will concentrate on the home-based entertainment business Let’s Explore Media. This will be expanded via acquisitions. The share price jumped 53.4% to 3.375p. Immotion joined AIM in July 2018 at a placing price of 10p a share.

Digital advertising services provider Dianomi (LON: DNM) says revenues were £35.8m in 2022 and EBITDA was £1.5m. There is a strong pipeline of potential new business this year and management indicates that second quarter advertising budgets are expected to improve. Even so, the growth rate of digital advertising has slowed. Dianomi is cautious about prospects and reducing costs, but after a long period of decline the share price has reacted positively, rising 25.9% to 85p.

AI-based cyber security services provider Smarttech247 (LON: S247) has won additional contracts. A US technology company has signed a three-year agreement worth $400,000 and a university in Ireland a two-year deal worth $450,000. The share price improved 8.47% to 32p. Last December’s placing price was 29.66p.

Share buying by finance director Steve Winters has sparked a recovery in the share price of digital transformation services provider TPXimpact (LON: TPX). He has acquired 220,000 shares at 21.34p each. The share price rose 7% to 23p, although it has still halved this week.

Transport and logistics company Xpediator (LON: XPD) says 2022 revenues were nearly £400m, up from £297m. This means that profit will be much better than the £9m previously expected. Net debt has more than halved over six months to £3.6m. Freight forwarding operations in Lithuania, Bulgaria and Romania performed particularly well. The loss making Beckton warehouse will be closed in February. Bid discissions continue concerning the indicative offer of 42p a share. The share price moved up 5.92% to 40.25p.

Floorcoverings supplier James Halstead (LON: JHD) says interim revenues grew by 8-9% in the first half, which was held back by shipping problems. International freight availability is improving. Supply concerns have eased, and stocks have been reduced. WH Ireland is maintaining its 2022-23 pre-tax profit forecast at £50.1m, down from £52.1m because of higher costs. The share price was 5.98% higher at 195p.

The Orcadian Energy (LON: ORCA) share price has declined 9.09% to 10p. That is the price at which it raised £500,000 to fund the development of the Pilot licence area in the North Sea.

Yesterday afternoon, medical imaging technology developer Polarean Imaging (LON: POLX) has gained New Chemical Entity designation from the US FDA for its drug product XENOVIEW. There is a designated five-year market exclusivity period. XENOVIEW is a hyperpolarised contrast agent prepared from the Xenon Xe 129 gas blend that is used in magnetic resonance imaging. It can be used for evaluation of lung ventilation for patients aged 12 and older. It does not expose the patients to ionising radiation. The share price had time to rise 13.8% to 46.1p yesterday, but it has fallen back 4.56% to 44p.  

88 Energy (LON: 88E) is raising up to £8.1m (A$15.1m) at 0.55p a share, which was a one-fifth discount to the previous closing price. The oil and gas company had A$14.1m in cash at the end of December. The cash will fund the Hickory-1 well at project Phoenix (formerly Icewine East) in Alaska, pay for new project Leonis acreage and provide working capital. There should be enough cash for at least 12 months. Management is also seeking additional projects. The share price fell 5.3% to 0.625p.

Growth is accelerating at PCI -PAL (LON: PCIP) and revenues were one-third higher in the six months to December 2022, helped by currency movements. First quarter growth was 29%. Total annualised contract revenues are £14.7m. Net cash fell to £1.9m, but this should be enough to reach profitability. The share price declined by 5.26% to 54p.

Ex-dividends

Greencoat Renewables (LON: GRP) is paying a dividend of 1.54 cents a share and the share price was down 1.25 cents to 111.75 cents.

Ramsdens Holdings (LON: RFX) is paying a final dividend of 6.3p a share and the share price fell 5.5p to 228.5p.

Totally (LON: TLY) is paying an interim dividend of 0.5p a share and the share price slipped 0.35p to 24.25p.

Watkin Jones (LON: WJG) is paying a final dividend of 4.5p a share and the share price is 3.5p lower at 109.9p.

Superdry – Julian Dunkerton has no ‘current’ plans to take company private

Well now we have been told.

Superdry (LON:SDRY) Founder and Chief Executive Julian Dunkerton has answered press rumours about the possibility that he will look to take his iconic brand private.

The group, which had problems last year with pressures on its refinancing of a £70m facility, coupled with operating losses, recently declared that it enjoyed good Christmas retail sales, but a lower take on its wholesaling side.

City press headlines suggested that Dunkerton, with others, was considering taking the group private.

However, he has now confirmed that “there were no plans to do this at the moment” but he reserves the right to make or participate in an offer for Superdry within the next six months.

But he may do so if another party made an offer or he had agreement with the Superdry Board.

Analyst Opinion – long-term value

Analyst Wayne Brown at Liberum Capital recently stated that the group’s shares are cheap and offer significant long-term value. 

He sees the group’s profits recovering from a current year (to end May) loss of some £6m, bouncing up to a profit of £9m on increased sales of £645m. 

For 2025 his estimates are for £690m sales and £23.5m profits, worth 21.8p per share in earnings.

He has maintained his Buy rating on the shares, with a 500p Target Price.

Conclusion – options kept open

With its shares trading at around 118p, the group is currently capitalised at about £97m.

That sounds like he is definitely keeping his options open!

Shell profit hits $40bn record in 2022

Shell recorded a $40bn profit in 2022 as higher oil and gas prices caused by Russian aggression in Ukraine drove profits to the highest level for 115 years.

Adjusted earnings for 2022 rose to $39.9bn from $19.2bn in 2021 as earnings across their integrated gas, upstream, and chemical and products business units soared.

Fourth quarter results showed the impact of higher oil and gas prices was heavily weighted to the summer months and earnings from their upstream production activities fell sharply in the last quarter of the year. Adjusted earnings for the fourth quarter fell to $3bn from $5.9bn in the third quarter as energy prices fell.

Integrated gas was the standout performer in the fourth quarter with adjusted earnings rising 157% to $5.9bn.

Shell shares were 1.9% higher at 1.9% at the time of writing.

“Despite lower oil and gas prices over the final quarter of 2022, Shell’s adjusted earnings rose to $9.8m from $9.4m in the previous quarter, with higher LNG trading and optimisation results,” said Derren Nathan, head of equity research, Hargreaves Lansdown.

“Total earnings for 2022 of $39.9m came in ahead of analyst expectations. This gave Shell the confidence to increase its final dividend by 15% and earmark $4bn for share buyback in the first quarter of 2023.”

Nathan also touched on how Shell is increasingly banging their renewables drum. Shell’s renewables unit recorded $1.7bn adjusted earnings in 2022 and marked a swing to profits from a $243m loss in 2021. Renewables earnings is still relatively insignificant compared to Shell’s overall profit, but the profit certainly signals Shell’s future intentions.

“Shell was keen to point out its expansion in renewables, such as the recent acquisition of biogas producer Nature Energy and its JV with Ecowende which has won a bid to develop a 760 MW offshore wind farm in the Netherlands. This comes against the backdrop of a complaint to the SEC by activist Group Global Witness, that Shell is overplaying its investments in renewables,” Nathan said.

BT revenue and profit falls in inflation-related slowdown

BT shares started Thursday trade on the back foot following a disappointing trading update for the nine months to end 31st December.

The telecoms company saw their revenue fall as a result of inflationary pressures, lower equipment sales and the removal of BT Sport revenue.

Revenue declined 1% while profit before tax for the period sank 15%. Profit before tax was heavily impacted by deprecation costs which offset a jump in EBITDA.

The lower profit was recorded despite efforts to lower costs across the business. The group plan to save £3bn in annualised costs by the end of 2025.

“Cost cuts remain the aim of the game as BT battles with higher costs from a host of angles. To be fair, management look to be doing a decent job and synergies from the newly created BT Business should help make the £3bn cost saving target a reality – but there’s no avoiding the fact cash flow is under pressure,” said Matt Britzman, equity analyst at Hargreaves Lansdown.

Analysts also pointed out the challenging nature of BT’s sector. There is increasing competition and their top line growth is kept in check by customer’s ability to switch providers and pressure from regulators. This creates a model that is heavily reliant on reducing costs to boost profits.

“Telecoms is a mighty challenging sector. There’s little to differentiate providers and regulators and consumers are always demanding more for less. So while BT is pushing through price increases, it must be careful not to push too hard,” said Charlie Huggins, Head of Equities at Wealth Club.

“Then there are the huge cash demands – BT will spend around £5 billion this year alone to maintain and upgrade its infrastructure, and it will have to keep the spending taps open to remain competitive. If inflation remains elevated, these costs are only likely to increase.”

BT shares were trading down 0.7% at 122p at the time of writing, after recovering from lower levels earlier in the session.

Why companies left AIM in December

There were twelve AIM cancelations during December 2022. Savannah Energy (LON: SAVE) was readmitted on 13 December after completing a deal with ExxonMobil. Kistos Holdings (LON: KIST) changed its holding company and was readmitted.
Three companies were taken over, three companies decided to leave, one what bust, one failed to return from suspension, one moved to the Main Market and the other decided to concentrate on its Nasdaq listing.
1 December 2022
Life Science REIT (LON: LABS)
Life Science REIT barely had a year on AIM, having joined on 19 November 2011 when it raised £350m at 100p a shar...

Additional FDA approval for Polarean Imaging diagnostic product

1

Medical imaging technology developer Polarean Imaging (LON: POLX) has gained New Chemical Entity designation from the US FDA for its drug product XENOVIEW. There is a designated five-year market exclusivity period. The share price rose 13.8% to 46.1p.  

XENOVIEW is a hyperpolarised contrast agent prepared from the Xenon Xe 129 gas blend that is used in magnetic resonance imaging. It can be used for evaluation of lung ventilation for patients aged 12 and older. It does not expose the patients to ionising radiation. This diagnostic technology could be relevant to more than 30 million Americans suffering from chronic lung disease.

A new clinical study is planned to expand the range of clinical applications for the technology. The trial is being designed.

Polarean Imaging is estimated to have generated revenues of £1.5m in 2022 and they are expected to jump to $9.8m this year. The XENOVIEW product could be eligible for reimbursement of $250/scan.  

Losses are set to continue to be significant and the cash pile will be reduced. Net debt could fall below $3m by the end of 2023. That suggests that a fundraising will be required in the next 12 months. If the latest news and other positive announcements push up the share price, then a fundraising will be less dilutive.